首頁 › 胰臟癌 › 德克薩斯州

德克薩斯州的胰臟癌臨床試驗

78 項針對胰臟癌的研究正在德克薩斯州各地點尋找參與者。

德克薩斯州的城市

官方研究文本（英文）

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Houston
Research Site, San Antonio

招募中1/2 期

18 至 130 歲 · 所有性別 · 更新於 2026年10月5日 · NCT05417594

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Texas Oncology - West Texas, Abilene
Texas Oncology - Austin, Austin
Texas Oncology - San Antonio, San Antonio
還有 1 項

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

UT MD Anderson Cancer Center, Houston

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center - Conroe, Conroe
University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston
還有 3 項

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Houston
PHN-012-001 Site, San Antonio

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT07127874

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

University of Texas MD Anderson Cancer Center, Houston

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07621718

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

START Dallas Fort Worth, Fort Worth
MD Anderson, Houston
NEXT Oncology Houston, Houston
還有 1 項

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07277413

DESTINY-PANTUMOUR04

Research Site, Dallas

招募中觀察性研究

18 至 130 歲 · 所有性別 · 更新於 2026年9月25日 · NCT07124000

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
還有 3 項

招募中2/3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06989437

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Texas Oncology - DFW, Dallas
University of Texas, Southwestern Medical Center, Dallas
University of Texas MD Anderson Cancer Center, Houston
還有 1 項

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Investigative Site US067, Dallas
Investigative Site US062, Denison
Investigative Site US011, Houston
還有 2 項

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

UT Southwestern Medical Center at Dallas, Dallas
Houston Methodist Office of Graduate - Houston Methodist Neal Cancer Center at Texas Medical Center, Houston

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT07409272